Coronavirus Notebook: Regulators To Work Together On Vaccine Evaluation, AstraZeneca In Russia Link-Up

 
• By Ian Schofield
  
Generate a summary of this article
Listen to this article
Beta

Collaboration is a key theme of this latest Pink Sheet round-up of COVID-19 news.

Vaccine coronavirus covid-19 ncov 2019 virus infection research, test, analysis. Coronavirus SARS-CoV-2 treatment vaccine injection laboratory testing, immunization, prevention 3D medical illustration
Collaboration is key on COVID-19 vaccines • Source: Shutterstock

The European Medicines Agency is working with other international regulators on vaccine evaluation, and there are encouraging new data on the efficacy of Russia’s Sputnik V vaccine. Also, AstraZeneca is linking up with the funders of Sputnik V to help boost efficacy of the UK vaccine it is developing with Oxford University. Finally, the medicines quality department at the Council of Europe has produced recommendations on the control of viral vectored vaccines to support COVID-19 candidate developers.

The European Medicines Agency is collaborating with a number of international authorities and regulators as well as the World Health...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography